David Ali

Acting CEO, Executive Director / Mediland Pharm

Dr Ali is a senior executive with more than 40 years experience in medical management, business development, sales and marketing for pharmaceutical, medical device and diagnostic companies in human and animal reproduction. He has held positions with prestigious organisations including CSIRO, Bayer, AstraZeneca, Novo Nordisk and Biogen. He was a member of the Association of Regulatory and Clinical Scientists where he also served an elected board term.

Lists and Charts

Roles

2024

Acting CEO, Executive Director

Mediland Pharm

2024

Acting CEO, Executive Director

Mediland Pharm

2024

Acting CEO, Executive Director

Memphasys

Year started and most recent title

Total Shareholder Return as at 02/12/24

Rank	Company	1 Yr	5 Yr
1535^th	NewPeak Metals">NewPeak Metals	-54.17%	-46.92%
1536^th	EcoGraf">EcoGraf	-54.29%	-3.38%
1537^th	Mediland Pharm">Mediland Pharm	-54.35%	-37.49%
1538^th	Memphasys">Memphasys	-54.35%	-37.49%
1539^th	Piedmont Lithium">Piedmont Lithium	-54.44%	11.38%

View Full List

1767 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®

Person Activity

	NEW ROLE: Acting CEO, Executive Director, Memphasys	01 Aug 2024
	NEW ROLE: Acting CEO, Executive Director, Mediland Pharm	01 Aug 2024
	NEW ROLE: Acting CEO, Executive Director, Mediland Pharm	01 Aug 2024

Related Information

Access to our data for David Ali is only available to paid subscribers with Data & Insights access.

Data & Insights is Western Australia's most accurate and comprehensive business listings and searchable database.

David Ali is linked to 3 organisations which are included in 1 list - Public Companies - non WA.

To see the data you will need to Subscribe.